Mesenchymal stem cells in cancer: Tumor-associated fibroblasts and cell-based delivery vehicles

Brett Hall, Jennifer Dembinski, A. Kate Sasser, Matus Studeny, Michael Andreeff, Frank Marini

Research output: Contribution to journalReview articlepeer-review

155 Scopus citations

Abstract

Recent evidence suggests that mesenchymal stem cells (MSC) selectively home to tumors, where they contribute to the formation of tumor-associated stroma. This effect can be opposed by genetically modifying MSC to produce high levels of anticancer agents that blunt tumor growth kinetics and inhibit the growth of tumors in situ. In this review article, we describe the biological properties of MSC within the tumor microenvironment and discuss the potential use of MSC and other bone marrow-derived cell populations as delivery vehicles for antitumor proteins.

Original languageEnglish (US)
Pages (from-to)8-16
Number of pages9
JournalInternational journal of hematology
Volume86
Issue number1
DOIs
StatePublished - Jul 2007

Keywords

  • Gene therapy
  • Mesenchymal stem cells
  • Stroma
  • Tumor microenvironment
  • Vascular network

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Mesenchymal stem cells in cancer: Tumor-associated fibroblasts and cell-based delivery vehicles'. Together they form a unique fingerprint.

Cite this